The Department of Stem Cell Biology and Regenerative Medicine (SCBRM) is positioned at the core of the Mount Sinai Health System, which provides valuable access to patient data and biological samples. The Icahn School of Medicine at Mount Sinai is ranked No. 4 in the United States for Cell Biology in the 2026-2027 U.S. News & World Report® Best Global Universities rankings. Our mission is to realize the potential of stem cell biology and regenerative medicine to identify new approaches to treat human disease and promote healthy aging.
Collaborative Research and Translational Impact
SCBRM brings together world-leading basic researchers using animal model systems to uncover the principles of developmental biology and tissue regeneration, and stem cell biologists and bioengineers who apply this knowledge to generate human stem cell-derived cells and organoids. These platforms are critical for developing robust human disease models, high-throughput drug screening, and advancing therapeutic transplantation techniques.”
Our interdisciplinary research portfolio and collaborative programs are generating crucial new insights into a broad spectrum of medical conditions, including: wound repair; hair loss; infertility; lung and liver disease; muscle wasting; congenital diseases affecting the craniofacial, hematopoietic, cardiac, and immune systems; neurodevelopmental conditions such as autism; neurodegenerative diseases including Alzheimer’s and Parkinson’s; childhood and adult cancers; and the fundamental processes of aging.
Integrated Centers and Clinical Acceleration
SCBRM researchers are active participants in the Tisch Cancer Institute, the Friedman Brain Institute, the Mindich Child Health & Development Institute, the Institute for Airway Sciences, the Diabetes, Obesity & Metabolism Institute, and the Sinai Skin Biology & Diseases Resouce-based Center, among other major interdisciplinary centers. We work closely with surgical teams to develop novel procedures involving stem cell-derived tissues and collaborate extensively with clinicians across the Health System to accelerate the translation of foundational discoveries into clinical applications.
Training and Scientific Leadership
SCBRM provides an exceptional environment for training the next generation of scientific leaders. Graduate students and postdoctoral fellows are directly engaged in cutting-edge research across diverse model systems and experimental platforms, benefiting from close mentorship and interdisciplinary collaboration. Department faculty are deeply committed to Mount Sinai's graduate and medical education programs, fostering the scientific curiosity, technical excellence, and innovative thinking required for leadership roles in academia, the biotechnology industry, and clinical medicine.
Under the leadership of its chair, Dr. Sarah Millar, SCBRM is focused on advancing regenerative therapies, sustaining excellence in training, and building the foundational knowledge for a new era in stem cell and regenerative biology that promises to fundamentally reshape our understanding, preservation, and restoration of human health.
June 2026:
- The Icahn School of Medicine at Mount Sinai is ranked No. 4 in the United States for Cell Biology in the 2026-2027 U.S. News & World Report® Best Global Universities rankings.
- We are delighted that our faculty members received recognition for their outstanding research at the 2026 Faculty Council Awards Ceremony on June 22, 2026:
- Dr. Elvin Wagenblast received the Faculty Council Junior Award.
- Dr. Andrew Ji received the Dr. Harold and Golden Lamport Clinical Research Award.
- Many congratulations to Dr. Wagenblast and Dr. Ji for their spectacular achievements!
Read the latest news coverage highlighting discoveries, collaborations, and research advances from the Department of Stem Cell Biology and Regenerative Medicine.
View selected publications that showcase the department’s contributions to stem cell biology, developmental biology, regenerative medicine, and disease modeling.
-
Adult RPE Cell Therapy Study: IND-enabling safety and efficacy of RPESC-RPE-4W, an adult RPE progenitor cell therapy for dry age-related macular degeneration
-
Human Corneal Organoids: Putative Self-Organizing Human Corneal Organoids Recapitulate Human Corneal Architecture and Cellular Diversity
-
Rea-Moreno M, Tian L, Tavakol TN, Yang MC, Pek NM, Gulati S, Bugacov H, Cusmai C, Dawodu G, Klotz RV, Garcia IM, Chen HY, Zhang CC, Pan H, Li X, Wolf AS, Huang H, Yu DH, Ichida JK, Sahoo S, Cannon PM, Que J, Scheinin SA, Laskey D, Vicencio AG, Januska MN, Guenthart BA, Johnson J, Yu M, Gu M, Tiozzo C, Chen YW. Unveiling alternate pathways for SARS-CoV-2 infection via extracellular vesicle-mediated transfer of ACE2 and TMPRSS2. Nat Commun. 2026 Apr 10;17(1):5102. doi: 10.1038/s41467-026-71680-w. PMID: 41963354; PMCID: PMC13246858.
-
Zhu X, Xu M, Portal C, Lin Y, Ferdinand A, Peng T, Morrisey EE, Dlugosz AA, Castellano JM, Lee V, Seykora JT, Wong SY, Iomini C, Millar SE. Identification of Meibomian gland stem cell populations and mechanisms of aging. Nat Commun. 2025 Feb 15;16(1):1663. doi: 10.1038/s41467-025-56907-6. PMID: 39955307; PMCID: PMC11830078: Mount Sinai-Led Research Team Identifies Underlying Mechanisms of Age-Related Dysfunction in Glands Crucial to Eye Function
-
Chu CW, Velayudhan SS, Schauser JH, Krishnakumar S, Yang S, Itoh K, Alfandari D, Trusina A, Sokol SY. Mechanical cues polarize ADIP protein complexes to control vertebrate morphogenesis and wound healing. Curr Biol. 2025 Jul 21;35(14):3315-3326.e4. doi: 10.1016/j.cub.2025.05.069. Epub 2025 Jun 24. PMID: 40562038; PMCID: PMC12321261.
A New Tradition Begins
We were proud to host the inaugural New York Stem Cell Club Meeting at the Icahn School of Medicine at Mount Sinai, bringing together more than 350 trainees, faculty, and scientists from across New York for a day of scientific exchange, networking, and career development.
What began as a trainee-driven vision became a truly community-wide effort. An organizing committee of 42 members representing 8 New York institutions and multiple career stages came together to build a meeting by the community, for the community.
We are grateful to Dean Eric Nestler for his support of the inaugural New York Stem Cell Club Meeting and for helping establish what we hope will become an enduring annual tradition.
Thank you to everyone who joined us for this exciting first chapter. We look forward to continuing to bring New York's stem cell community together for years to come.